The Effect of Tirzepatide on Weight, Lipid Metabolism and Blood Pressure in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Journal Information
Full Title: Diabetes Metab Syndr Obes
Abbreviation: Diabetes Metab Syndr Obes
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology & Metabolism
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure The manuscript has no financial relationship with any institution and all authors claim no conflict of interest."
"This study was funded by the National Natural Science Foundation of China (No.81960155), Natural Science Foundation of Gansu Province (20JR10RA690) and The Hospital Fund of the First Hospital of Lanzhou University (ldyy-2021-01)."
"The PubMed, Embase, Cochrane Library and Web of Science databases were systematically searched from their inception until December 2022 for literature on TZP treatment for overweight/obese T2DM patients. The literature search included the following keywords: Type 2 diabetes mellitus, Tirzepatide, body weight, lipids, blood pressure, and others. The selected studies were presented and reported in accordance with the PRISMA-P System Evaluation Reporting Guidelines. Predefined schemes were registered with PROSPERO under the registration number CRD42022370543."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025